Search Results
Jan 15, 2026, 19:00 ET JPM 2026 | 科倫博泰CEO葛均友博士全面展示公司創新成果及未來發展戰略
View original content to download multimedia:https://www.prnewswire.com/apac/zh/news-releases/jpm-2026--ceo-302662246.htmlSOURCE 科倫博泰
More news about: 科倫博泰
Jan 15, 2026, 13:30 ET Kelun-Biotech Showcases Innovative Achievements and Future Development Strategy at the 44th Annual JPM Healthcare Conference
multimedia:https://www.prnewswire.com/news-releases/kelun-biotech-showcases-innovative-achievements-and-future-development-strategy-at-the-44th-annual-jpm-healthcare-conference-302662289.htmlSOURCE
More news about: Kelun-Biotech
Jan 14, 2026, 23:00 ET JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth
content:https://www.prnewswire.com/news-releases/jpm-highlights--wuxi-biologics-ceo-dr-chris-chen-scaled-crdmo-platform-delivering-sustainable-high-growth-302661742.htmlSOURCE
More news about: WuXi Biologics
Jan 13, 2026, 13:00 ET Former Drawbridge Health CEO Launches Manifold Health AI at JPM to Build the First Digital Health Index Twin for Chronic Disease
SAN FRANCISCO, Jan. 13, 2026 /PRNewswire/ -- Manifold Health AI today announced its launch at JPM Healthcare Week and the GMT MedTech Symposium, unveiling a first-to-market platform that combines a novel, precision-designed blood test with an AI-driven
More news about: Manifold Health
Jan 13, 2026, 09:10 ET Biokin to Present at J.P. Morgan's 44th Annual Healthcare Conference
JPM 2026 SystImmune Webcast Presentation, with materials related to the presentation available at the start of the live webcast. A replay and archived
More news about: SystImmune, Inc.
Jan 12, 2026, 14:05 ET Kipu Introduces the First Intelligent Operating System for Behavioral Healthcare Industry
New Kipu Helix Platform and Kipu Circle Partner Ecosystem unveiled during JPM WeekMIAMI, Jan. 12, 2026 /PRNewswire/ --
More news about: Kipu Health
Jan 12, 2026, 08:55 ET NYSE Content Advisory: Pre-Market Update + NYSE Takes Its Bell on the Road to JPMorgan's Healthcare Event
connecting with NYSE community leaders—watch for those interviews soon on our app. Opening Bell JPMorgan Chase (NYSE: JPM) kicks off the 2026 J.P. Morgan Healthcare Conference Closing Bell Riskified (NYSE: RSKD) celebrates another successful year
More news about: New York Stock Exchange
Jan 12, 2026, 08:00 ET AlphaSense to Outline AI Trends Impacting Drug Discovery and R&D Investment in Biotech and Pharmaceutical Industries at Fierce JPM Week Conference
Fierce JPM Week, one of the world's most influential healthcare and biotech events, as industry leaders navigate imperatives to redefine business models,
More news about: AlphaSense
Jan 12, 2026, 08:00 ET Cytotheryx Secures Lead Investor for $60M Series A; Confirms Debt Financing to Expand Facilities
Biotech Showcase during JPM Week in San Francisco on Monday, January 12, at 2:30 p.m. PST. Safe Harbor StatementThis press release contains forward-looking
More news about: Cytotheryx, Inc.
Jan 12, 2026, 07:00 ET EDETEK to Present at the 44th Annual J.P. Morgan Healthcare Conference
ReplayEDETEK will consider webcast and replay requests made via its website for a limited time following the event. To schedule a meeting during JPM, visit
More news about: EDETEK, Inc.
Jan 08, 2026, 16:47 ET Antheia CEO Joins Fierce JPM Week as Panelist Speaker on Onshoring Pharmaceutical Supply Chains
delivering 21st-century pharmaceutical manufacturing and innovation, today announced that CEO and co-founder, Dr. Christina Smolke will join Fierce JPM Week as a featured panelist. Dr. Smolke will discuss the historic effort to onshore pharmaceutical supply chains to the U.S. and the critical role of
More news about: Antheia
Jan 08, 2026, 10:00 ET Zifo at JPM Healthcare Conference 2026: Why Technology Alone Cannot Deliver the AI Promise
content:https://www.prnewswire.com/news-releases/zifo-at-jpm-healthcare-conference-2026-why-technology-alone-cannot-deliver-the-ai-promise-302656459.htmlSOURCE
More news about: Zifo Technologies
Jan 08, 2026, 09:00 ET Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity
Dyhrfjeld-Johnsen (CSO & CDO) will attend JPM Week in San Francisco (January 12–15, 2026) and welcome the opportunity to engage with investors and strategic partners during the Biotech Showcase (company presentation: Tuesday, January 13, 2:15 PM PT) and BIO Partnering @ JPM Week.About ACOU085 (Bimokalner):ACOU085
More news about: Acousia Therapeutics GmbH
Jan 08, 2026, 09:00 ET Kazia Therapeutics to Participate in J.P. Morgan Healthcare Conference Week; Clinical and Translational Update Anticipated Before Month-End
Executive Officer, John Friend, MD, will be in San Francisco next week to participate in meetings during the annual J.P. Morgan Healthcare Conference week (JPM Week). During the week, Kazia will connect with existing and prospective institutional investors, sell-side analysts, and strategic collaborators,
More news about: Kazia Therapeutics Limited
Jan 07, 2026, 08:00 ET Digital Asset and Kinexys by J.P. Morgan announce intention to bring USD JPM Coin (JPMD) natively to the Canton Network
blockchain infrastructure.In bringing JPM Coin natively to Canton, Digital Asset and Kinexys by J.P. Morgan are laying the foundation for regulated, interoperable digital money that can move seamlessly across financial markets. With native availability of JPM Coin, institutions using Canton will be
More news about: Canton Network
Jan 06, 2026, 10:44 ET Boulder iQ Participates in RESI JPM, MD&M West
RESI JPM 2026: Jan. 14, 19, 20 (virtual)This RESI will take place concurrently with JP Morgan Healthcare Week. As the largest and most comprehensive
More news about: Boulder iQ
Jan 06, 2026, 08:30 ET 'Scripting Possibilities' in Biotechnology: Global Innovators Converge in San Francisco for GenScript's 5th Annual Biotech Forum During JPM Week
multimedia:https://www.prnewswire.com/news-releases/scripting-possibilities-in-biotechnology-global-innovators-converge-in-san-francisco-for-genscripts-5th-annual-biotech-forum-during-jpm-week-302653459.htmlSOURCE
More news about: GenScript Biotech Corporation
Jan 05, 2026, 04:47 ET Curasight to hold Meetings in San Francisco During J.P. Morgan Healthcare Conference Week
https://mb.cision.com/Main/19744/4288616/3862590.pdfCurasight Press release - JPM 26
More news about: Curasight
Jan 05, 2026, 04:45 ET Curasight to hold Meetings in San Francisco During J.P. Morgan Healthcare Conference Week
https://mb.cision.com/Main/19744/4288616/3862590.pdfCurasight Press release - JPM 26
More news about: Curasight
Jan 01, 2026, 01:00 ET ImmunoForge to Host Strategic Partnering Meetings During J.P. Morgan Healthcare Conference 2026
licensing rights (excluding Korea) are open for discussion, offering a validated opportunity for international partners."Our goal for JPM 2026 week is to meet with potential partners who can leverage our FDA-cleared INDs to rapidly bring these therapies to the U.S. market," said a representative
More news about: ImmunoForge
Dec 24, 2025, 08:55 ET Jason Zhu, PDG de Henlius, prononcera une allocution lors de la conférence JPM 2026
content:https://www.prnewswire.com/news-releases/jason-zhu-pdg-de-henlius-prononcera-une-allocution-lors-de-la-conference-jpm-2026-302649261.html
More news about: Henlius
Dec 24, 2025, 08:54 ET El consejero delegado de Henlius, Dr. Jason Zhu, realizará una presentación magistral en JPM 2026
content:https://www.prnewswire.com/news-releases/el-consejero-delegado-de-henlius-dr-jason-zhu-realizara-una-presentacion-magistral-en-jpm-2026-302649259.html
More news about: Henlius
Dec 24, 2025, 06:56 ET Dr. Jason Zhu, Geschäftsführer von Henlius, hält eine Grundsatzrede auf der JPM 2026
content:https://www.prnewswire.com/news-releases/dr-jason-zhu-geschaftsfuhrer-von-henlius-halt-eine-grundsatzrede-auf-der-jpm-2026-302649232.html
More news about: Henlius
Dec 23, 2025, 09:05 ET Henlius CEO Dr. Jason Zhu to Deliver a Keynote Presentation at JPM 2026
content:https://www.prnewswire.co.uk/news-releases/henlius-ceo-dr-jason-zhu-to-deliver-a-keynote-presentation-at-jpm-2026-302648774.html
More news about: Henlius
Dec 23, 2025, 08:53 ET Henlius CEO Dr. Jason Zhu to Deliver a Keynote Presentation at JPM 2026
content:https://www.prnewswire.com/news-releases/henlius-ceo-dr-jason-zhu-to-deliver-a-keynote-presentation-at-jpm-2026-302648763.htmlSOURCE
More news about: Henlius